文献速递儿科与产科急症

自身免疫性疾病与不良妊娠结局:一项伞状综述

Autoimmune diseases and adverse pregnancy outcomes: an umbrella review.
PubMed 文献 · Lancet · 2023-01-01
一句话结论患有自身免疫性疾病的孕妇发生流产、子痫前期、妊娠期糖尿病、胎儿生长受限等多种不良妊娠结局的风险增高,需加强孕前至产后全程管理。

该伞状综述检索了截至2022年9月30日的Medline、Embase和Cochrane数据库,纳入33篇系统综述(含709项原始研究),评估自身免疫性疾病与不良妊娠结局的关联。结果显示,干燥综合征(RR 8.85)、系统性红斑狼疮(OR 4.90)、甲状腺自身免疫(OR 2.77)、系统性硬化症(OR 1.60)和乳糜泻(OR 1.38)孕妇流产风险增高;1型糖尿病(OR 4.19)和SLE(OR 3.20)孕妇子痫前期风险增高;炎症性肠病(OR 2.96)和甲状腺自身免疫(OR 1.49)孕妇妊娠期糖尿病风险增高。此外,系统性硬化症和乳糜泻孕妇胎儿生长受限风险、SLE和类风湿关节炎孕妇小于胎龄儿风险亦增高。作者认为需进一步研究以改善自身免疫性疾病女性的孕前至产后护理。

要点

  • 干燥综合征孕妇流产风险显著增高(RR 8.85,95%CI 3.10-25.26),为所有自身免疫病中流产风险最高者。
  • SLE孕妇流产(OR 4.90,95%CI 3.10-7.69)、子痫前期(OR 3.20,95%CI 2.54-4.20)及小于胎龄儿(OR 2.49,95%CI 1.88-3.31)风险均增高。
  • 1型糖尿病孕妇子痫前期风险增高(OR 4.19,95%CI 3.08-5.71),但小于胎龄儿风险降低(OR 0.68,95%CI 0.56-0.83)。
  • 炎症性肠病孕妇妊娠期糖尿病风险增高(OR 2.96,95%CI 1.47-5.98),甲状腺自身免疫孕妇妊娠期糖尿病风险亦增高(OR 1.49,95%CI 1.07-2.07)。
  • 系统性硬化症孕妇流产(OR 1.60,95%CI 1.29-2.22)和胎儿生长受限(OR 3.20,95%CI 2.21-4.53)风险增高;乳糜泻孕妇流产(OR 1.38,95%CI 1.12-1.69)和胎儿生长受限(OR 1.71,95%CI 1.36-2.14)风险增高。

适用人群与场景

  • 患有自身免疫性疾病的孕妇,包括干燥综合征、系统性红斑狼疮、甲状腺自身免疫、系统性硬化症、乳糜泻、1型糖尿病、炎症性肠病和类风湿关节炎。

研究设计与关键结果

  • 伞状综述纳入33篇系统综述,包含709项原始研究,检索Medline、Embase和Cochrane数据库自建库至2022年9月30日,无语言限制。
  • 流产风险:干燥综合征RR 8.85(95%CI 3.10-25.26),SLE OR 4.90(95%CI 3.10-7.69),甲状腺自身免疫OR 2.77(95%CI 2.10-3.65),系统性硬化症OR 1.60(95%CI 1.29-2.22),乳糜泻OR 1.38(95%CI 1.12-1.69)。
  • 子痫前期风险:1型糖尿病OR 4.19(95%CI 3.08-5.71),SLE OR 3.20(95%CI 2.54-4.20)。
  • 妊娠期糖尿病风险:炎症性肠病OR 2.96(95%CI 1.47-5.98),甲状腺自身免疫OR 1.49(95%CI 1.07-2.07)。
  • 胎儿生长受限风险:系统性硬化症OR 3.20(95%CI 2.21-4.53),乳糜泻OR 1.71(95%CI 1.36-2.14)。
  • 小于胎龄儿风险:SLE OR 2.49(95%CI 1.88-3.31),类风湿关节炎OR 1.49(95%CI 1.22-1.82)。
  • 1型糖尿病女性小于胎龄儿结局的比值比降低(OR 0.68,95%CI 0.56-0.83)。
  • 其他胎儿结局如死产、早产和低出生体重的风险在患有自身免疫性疾病的孕妇中亦增高。

证据类型、等级与局限

  • 证据类型:伞状综述,纳入33篇系统综述(含709项原始研究),采用AMSTAR 2进行质量评价。
  • 局限性:作者指出需进一步研究以制定更好的孕前至产后护理方案。

对床旁实践的改变

  • 作者认为,患有自身免疫性疾病的孕妇发生不良妊娠结局的风险更高,需要进一步研究以改善这一人群从孕前到产后的护理。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The prevalence of autoimmune conditions is two-fold higher in women than in men, especially during the reproductive years. Autoimmune conditions have been associated with a greater risk of adverse pregnancy outcomes, and some conditions have been studied more than others with inconsistent findings. The objective of this umbrella review was to identify, appraise, synthesise, and consolidate findings from published systematic reviews of autoimmune conditions and adverse pregnancy outcomes.

METHODS: In this umbrella review, we searched Medline, Embase, and Cochrane databases for systematic reviews from inception to Sept 30, 2022, without language restrictions. We used the Medical Subject Headings and free text search for autoimmune conditions and pregnancy outcomes. Screening, data extraction, and quality appraisal (AMSTAR 2) were done by two independent reviewers. Data was extracted using a standardised form, which was piloted before use. Data were synthesised narratively and quantitatively. Odds ratios (ORs) with 95% CIs were reported. The protocol has been registered to PROSPERO (CRD42022334992).

FINDINGS: We selected 33 reviews, which included 709 primary studies. Pregnant women with autoimmune conditions were at high risk of both adverse maternal and fetal outcomes. The risk of miscarriage was increased in pregnant women with Sjögren's syndrome (relative risk [RR] 8·85, 95% CI 3·10-25·26), systemic lupus erythematosus (SLE; OR 4·90, 95% CI 3·10-7·69), thyroid autoimmunity (OR 2·77, 2·10-3·65), systemic sclerosis (OR 1·60, 1·29-2·22), and coeliac disease (OR 1·38, 1·12-1·69). The risk of pre-eclampsia was increased in pregnant women with type 1 diabetes (T1DM; OR 4·19, 3·08-5·71) and SLE (OR 3·20, 2·54 - 4·20). The risk of gestational diabetes was increased in pregnant women with inflammatory bowel disease (IBD; OR 2·96, 1·47-5·98) and thyroid autoimmunity (OR 1·49, 1·07-2·07). The risk of intrauterine growth restriction (IUGR) was increased in pregnant women with systemic sclerosis (OR 3·20, 2·21-4·53) and coeliac disease (OR 1·71, 1·36-2·14). The risk of delivering a small-for-gestational age baby was increased in pregnant women with SLE (OR 2·49, 1·88-3·31) and rheumatoid arthritis (OR 1·49, 1·22-1·82). The risks of other fetal outcomes such as stillbirth, preterm birth, and low birthweight were also increased in pregnant women with autoimmune disorders. T1DM in women was associated with lower odds of small-for-gestational-age outcome (OR 0·68, 0·56-0·83).

INTERPRETATION: Pregnant women with autoimmune conditions are at greater risk of developing adverse pregnancy outcomes. Further research is required to develop better preconception to post-natal care for women with autoimmune conditions.

FUNDING: Medical Research Council (MRC) and the National Institute for Health and Care Research (NIHR).

来源:Lancet,查看原文。版权归原作者所有。

参考来源

  1. Singh M, Wambua S, Lee SI, et al. Autoimmune diseases and adverse pregnancy outcomes: an umbrella review. Lancet. 2023. PMID: 37997130. doi:10.1016/S0140-6736(23)02128-1

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。